Novel approach in HIV therapy: lipid nanoparticle-based mRNA delivery technology using LNP X-HIV Tat-CRISPRa system
Open Access
- 31 August 2025
- journal article
- Published by Maad Rayan Publishing Company in Advanced Pharmaceutical Bulletin
- Vol. 15 (3) , 479-481
Abstract
Novel approach in HIV therapy: lipid nanoparticle-based mRNA delivery technology using LNP X-HIV Tat-CRISPRa systemKeywords
This publication has 7 references indexed in Scilit:
- Efficient mRNA delivery to resting T cells to reverse HIV latencyNature Communications, 2025
- Inclusion of a retroviral protease enhances the immunogenicity of VLP-forming mRNA vaccines against HIV-1 or SARS-CoV-2 in miceScience Translational Medicine, 2025
- HIV Tat as a latency reversing agent: turning the tables on viral persistenceFrontiers in Immunology, 2025
- mRNA vaccines against HIV: Hopes and challengesHIV Medicine, 2025
- Four decades of continuing innovations in the development of antiretroviral therapy for HIV/AIDS: Progress to date and future challengesGlobal Health & Medicine, 2023
- A CRISPR-Cas Cure for HIV/AIDSInternational Journal of Molecular Sciences, 2023
- Between a shock and a hard place: challenges and developments in HIV latency reversalCurrent Opinion in Virology, 2019